Onesource Specialty Pharma Limited — Updates, 04-05-2026: Press Release

OneSource's partner secured Canadian approval for generic semaglutide (Ozempic), positioning them as first generic entrants. OneSource, as manufacturing partner, provided end-to-end support from its US FDA-approved facility. This follows a US tentative approval, reinforcing its global CDMO expertise in complex injectables.